1.Predictors of mortality among end-stage renal disease patients with COVID-19 admitted in a Philippine Tertiary Government Hospital: A retrospective cohort study
Saul B. Suaybaguio ; Jade D. Jamias ; Marla Vina A. Briones
Acta Medica Philippina 2024;58(Early Access 2024):1-8
Background and Objective:
Several studies have examined the predictors of mortality among COVID-19-infected
patients; however, to date, few published studies focused on end-stage renal disease patients. The present study,therefore, aims to determine the predictors of in-hospital mortality among end-stage renal disease patients with COVID-19 admitted to a Philippine tertiary hospital.
Methods:
The researcher utilized a retrospective cohort design. A total of 449 adult end-stage renal disease patients on renal replacement therapy diagnosed with moderate-to-severe COVID-19 and were admitted at the National Kidney and Transplant Institute from June 2020 to 2021 were included. Logistic regression analysis was used to determine the factors associated with in-hospital mortality.
Results:
In-hospital mortality among end-stage renal disease patients with COVID-19 was 31.18% (95% CI: 26.92-
35.69%). Older age (OR=1.03), male sex (OR=0.56), diabetes mellitus (OR=1.80), coronary artery disease (OR=1.71), encephalopathy (OR=7.58), and intubation (OR=30.78) were associated with in-hospital mortality.
Conclusion
Patients with ESRD and COVID-19 showed a high in-hospital mortality rate. Older age, diabetes mellitus, coronary artery disease, encephalopathy, and intubation increased the odds of mortality. Meanwhile, males had lower odds of mortality than females.
COVID-19
;
Kidney Failure, Chronic
;
Hospital Mortality
;
Renal Replacement Therapy
2.Comparison of clinical characteristics of patients with acute kidney injury after intravenous versus inhaled colistin therapy.
A Young CHO ; Hyun Ju YOON ; Jung Cheol LEE ; Jin Young KWAK ; Kwang Young LEE ; In O SUN
Kidney Research and Clinical Practice 2016;35(4):229-232
BACKGROUND: The aim of this study was to investigate the incidence and clinical characteristics of intravenous (IV) or inhaled (IH) colistin-associated acute kidney injury (AKI) using the Risk, Injury, Failure, Loss, End-stage Renal Disease criteria. METHODS: From 2010 to 2014, 160 patients were treated with IV or IH colistin. Of these, we included 126 patients who received colistin for > 72 hours for the treatment of pneumonia and compared the incidence and clinical characteristics of patients in the IV (n = 107) and IH (n = 19) groups. RESULTS: The patients included 104 men and 22 women, with a mean age of 69 years (range, 24–91 years). The mortality rate was 45%, and AKI occurred in 75 (60%) patients. At the end of therapy, the bacteriologic cure rate was 66%. There were no differences in the clinical characteristics between the IV and IH groups except for age. In comparison with patients in the IV group, the patients in the IH group were older (74 ± 8 vs. 68 ± 12 years, P = 0.026). The incidence of AKI was not different between the 2 groups (62 vs. 47%, P = not significant), and there was no difference in the severity of AKI according to the Risk, Injury, Failure, Loss, End-stage Renal Disease criteria. Of the 83 patients with AKI, 6 and 1 patients underwent renal replacement therapy, respectively. CONCLUSION: The incidence of AKI in patients with colistin therapy is 60% in our center. It seems that IH colistin therapy could not be better in safety than IV colistin therapy.
Acute Kidney Injury*
;
Colistin*
;
Female
;
Humans
;
Incidence
;
Kidney Failure, Chronic
;
Male
;
Mortality
;
Nebulizers and Vaporizers
;
Pneumonia
;
Renal Replacement Therapy
3.Predictive Value of Echocardiographic Parameters for Clinical Events in Patients Starting Hemodialysis.
Seung Seok HAN ; Goo Yeong CHO ; Youn Su PARK ; Seon Ha BAEK ; Shin Young AHN ; Sejoong KIM ; Ho Jun CHIN ; Dong Wan CHAE ; Ki Young NA
Journal of Korean Medical Science 2015;30(1):44-53
Echocardiographic parameters can predict cardiovascular events in several clinical settings. However, which echocardiographic parameter is most predictive of each cardiovascular or non-cardiovascular event in patients starting hemodialysis remains unresolved. Echocardiography was used in 189 patients at the time of starting hemodialysis. We established primary outcomes as follows: cardiovascular events (ischemic heart disease, cerebrovascular disease, peripheral artery disease, and acute heart failure), fatal non-cardiovascular events, all-cause mortality, and all combined events. The most predictable echocardiographic parameter was determined in the Cox hazard ratio model with a backward selection after the adjustment of multiple covariates. Among several echocardiographic parameters, the E/e' ratio and the left ventricular end-diastolic volume (LVEDV) were the strongest predictors of cardiovascular and non-cardiovascular events, respectively. After the adjustment of clinical and biochemical covariates, the predictability of E/e' remained consistent, but LVEDV did not. When clinical events were further analyzed, the significant echocardiographic parameters were as follows: s' for ischemic heart disease and peripheral artery disease, LVEDV and E/e' for acute heart failure, and E/e' for all-cause mortality and all combined events. However, no echocardiographic parameter independently predicted cerebrovascular disease or non-cardiovascular events. In conclusion, E/e', s', and LVEDV have independent predictive values for several cardiovascular and mortality events.
*Echocardiography
;
Female
;
Heart Failure/*diagnosis/mortality
;
Humans
;
Kidney Failure, Chronic/mortality/*therapy
;
Male
;
Middle Aged
;
Predictive Value of Tests
;
Prognosis
;
*Renal Dialysis
;
Risk Factors
;
Ventricular Function, Left/*physiology
4.In-Hospital Outcomes of Acute Renal Failure Requiring Continuous Renal Replacement Therapy in Patients with On-pump CABG.
Young Du KIM ; Kuhn PARK ; Kuhn Hyun JO ; Chul Ung KANG ; Jeong Seob YOON ; Seok Whan MOON ; Young Pil WANG
The Korean Journal of Thoracic and Cardiovascular Surgery 2007;40(1):32-36
BACKGROUND: Although acute renal failure (ARF) after coronary artery bypass graft (CABG) is relatively rare, but devastating complication with high mortality. Our study aims to evaluate the effectiveness of early application of CRRT in patients with ARF which developed after on-pump CABG. MATERIAL AND METHOD: Two hundred and eighty seven patients underwent isolated on-pump CABG between May 2002 and Feb. 2006 at our institution, of whom 15 (5.2%) needed CRRT (11 patients for postoperatively developed ARF and the remaining 4 patients with pre- existing dialysis-dependent chronic renal failure (CRF) for postoperative hemodynamic and metabolic control). Criteria for early application of CRRT were as follows; decreased urine output less than 0.5 cc/h/kg for 2 consecutive hours and elevated serum creatinine level greater than 2.0 mg/dL. RESULT: The incidence of ARF requiring CRRT after on-pump CABG was 3.9% (11/283) and the overall hospital mortality of patient with CRRT was 33.3% (5/15). Of 5 deaths, 4 were patients with postoperatively developed ARF, and 1 was a patient with pre-existing dialysis- dependent CRF patient. The mean time between the operation and the initiation of CRRT was 25.8+/-5.8 hours and the mean duration of CRRT was 62.1+/-41.2 hours. Of the 7 survivors who were not on dialysis-dependent preoperatively, 6 patients fully recovered renal function during hospital stay and 1 patient required permanent renal supportive treatment after discharge from hospital. CONCLUSION: Early application of CRRT could maintain stable postoperative hemodynamic status and make outcomes better than those of previous reports in patients with ARF which developed after on-pump CABG.
Acute Kidney Injury*
;
Coronary Artery Bypass
;
Creatinine
;
Hemodynamics
;
Hospital Mortality
;
Humans
;
Incidence
;
Kidney Failure, Chronic
;
Length of Stay
;
Mortality
;
Renal Replacement Therapy*
;
Survivors
;
Transplants
5.Survival Analysis of Korean End-Stage Renal Disease Patients According to Renal Replacement Therapy in a Single Center.
Young Soo SONG ; Heesun JUNG ; Jinyoung SHIM ; Changkwon OH ; Gyu Tae SHIN ; Heungsoo KIM
Journal of Korean Medical Science 2007;22(1):81-88
This study was to investigate clinical characteristics and any differential trends in survival among renal replacement therapy (hemodialysis [HD], peritoneal dialysis [PD], and kidney transplantation [KT]) in Korean end-stage renal disease (ESRD) population. We tried to analyze retrospectively the survival rate adjusted by risk factors and the relative risk stratified by key risk factors among 447 ESRD patients who began dialysis or had a kidney transplant at Ajou University Hospital from 1994 to 2004. In adjusted Cox survival curves, the KT patients had the best survival rate, and the HD patients had better survival than PD patients. The consistent trends in different subgroups stratified by age and diabetes were as following: 1) The risk of death for PD and HD was not proportional over time, 2) The relative risk of PD was similar or lower than that of HD for the first 12 months, but it became higher at later period. The significant predictors for mortality were age (over 55 yr), presence of diabetes, cerebrovascular accident at ESRD onset, and more than one time of hospitalization caused by malnutrition. Further large-scaled, multicenter-based comparative study is needed in Korean ESRD patients and more meticulous attention is required in high-risk patients.
Survival Analysis
;
Renal Replacement Therapy/*mortality
;
Morbidity
;
Middle Aged
;
Male
;
Kidney Transplantation
;
Kidney Failure, Chronic/*mortality
;
Humans
;
Follow-Up Studies
;
Female
;
Aged
;
Adult
6.Effects of interim hemodialysis on survival and clinical outcomes in patients with maintenance peritoneal dialysis.
Wei BIAN ; Jichao GUAN ; Xishao XIE ; Jin TONG ; Xiaohui ZHANG ; Zhangfei SHOU
Journal of Zhejiang University. Medical sciences 2016;45(2):195-200
OBJECTIVETo investigate the effects of interim hemodialysis (HD) on survival and clinical outcomes in patients with maintenance peritoneal dialysis (PD).
METHODSThe clinical data of 908 patients undergoing maintenance PD from January 2010 to December 2014 registered in Zhejiang Dialysis Regisration System were retrospectively analyzed. Among all PD patients, 176 cases received interim HD for less than 3 months, and then transferred to PD (transfer group) and 732 cases had initial PD (non-transfer group). The demographic parameters, biochemical data, comorbidity, details of peritonitis and transplantation were documented. Survival curves were made by the Kaplan-Meier method; univariate and multivariate analyses were performed with Cox proportional hazard regression model to identify risk factors of mortality.
RESULTSCompared with patients in transfer group, patients in non-transfer group had significantly higher serum albumin and total Kt/V levels. The survival rate was significantly higher in non-transfer group, but there was no significant difference in technique survival between two groups. After multivariable adjustment, initial dialysis modality (HR=1.60, 95% CI: 1.01~2.56), age (HR=1.07, 95% CI:1.05~1.09) and serum albumin (HR=0.96, 95% CI: 0.93~0.99) and Charslon comorbidity index (HR=2.54, 95% CI:1.63~3.94) were independent factors for long-term survival.
CONCLUSIONPatients who transfer to PD after interim HD have lower survival rate than patients who start with and are maintained on PD. HD is an independent risk factor for PD patients, therefore, patients with PD should be well informed and educated with dialysis protocols.
Humans ; Kidney Failure, Chronic ; mortality ; therapy ; Peritoneal Dialysis ; Proportional Hazards Models ; Renal Dialysis ; Retrospective Studies ; Risk Factors ; Survival Rate
7.Psychosocial Factors in Patients with Chronic Kidney Disease.
Hanyang Medical Reviews 2014;34(2):77-80
This review article is intended to show and understand psychosocial factors in patients with chronic kidney disease (CKD) including end-stage renal disease (ESRD) on renal replacement therapy. These patients suffered from many psychosocial factors such as depression, sleep disorder, and chronic pain, etc. The prevalence of major depression or a defined psychiatric illness in ESRD patients is not clearly defined, but is roughly estimated between 5% and 50%. Unfortunately many sufferers do not seek treatment, and of those who do, significant numbers are improperly diagnosed or are not appropriately treated. They should be managed by psychiatric medication and interview, because depression could affect medical outcomes in ESRD patients through several mechanisms. Sleep disorders are common in ESRD patients treated with dialysis and are associated with patients' perceptions of quality of life, assessed by diverse measures, as well as depressive mood. Although pain has been considered as a problem for ESRD patients for more than 20 years, few studies exist on this subject. Pain appears to be an undervalued problem for ESRD patients. These psychosocial factors could affect morbidity, mortality and life quality in CKD and ESRD patients. The physicians, especially managing CKD patients, need to consider these factors.
Chronic Pain
;
Depression
;
Dialysis
;
Dyssomnias
;
Humans
;
Kidney Failure, Chronic
;
Mortality
;
Prevalence
;
Psychology*
;
Quality of Life
;
Renal Insufficiency, Chronic*
;
Renal Replacement Therapy
;
Sleep Wake Disorders
8.Prognosis of microscopic polyangiitis with renal involvement: report of 60 Chinese patients.
Wei-xin HU ; Zhi-hong LIU ; Chun-bei LIU ; Zheng TANG ; Qing-wen WANG ; Hui-ping CHEN ; Lei-shi LI
Chinese Medical Journal 2005;118(24):2089-2092
Adolescent
;
Adult
;
Aged
;
Female
;
Humans
;
Kidney Failure, Chronic
;
mortality
;
Male
;
Middle Aged
;
Prognosis
;
Renal Replacement Therapy
;
Retrospective Studies
;
Survival Rate
;
Vasculitis
;
complications
;
mortality
9.Renal transplantation in children, report of 21 cases.
Wei-zhen WU ; Li-yan YE ; Jian-ming TAN ; Liang-ming OU ; Rong-xi LIN
Chinese Journal of Pediatrics 2003;41(11):804-807
OBJECTIVEThe survival rate of cadaveric renal transplant in children has been improved following the development of transplantation technology and the application of immunosuppressive agents. In this study, the prognosis of renal transplantation, operative procedure and immunosuppressive agents administration in 21 children with end-stage renal disease (ESRD) were analyzed.
METHODSFrom January 1985 to December 2001, 21 patients (9 males and 12 females with a mean age of 14 +/- 2 yr, mean body weight of 33.4 kg and mean height of 136.5 cm) received renal transplantation because of ESRD were enrolled in the study. The patients with an average GFR of 8.28 ml/min were managed with dialysis for 13.4 months in average pro-transplantation. All cadaveric kidneys were from adults, which included 1 donor with one HLA mismatch, 3 with two mismatches, 5 with three mismatches and 4 with four mismatches. All transplantations were performed with anastomoses of the adults' renal artery and vein to the children's iliac externa artery and iliac externa vein. Biological inducement therapy was given in 4 cases. At the first 3 - 5 days post-transplantation, methylprednisolone was administered [7 mg/(kg.d)]. All patients received baseline diploid or triple immunosuppression therapy of cyclosporin A [6 - 8 mg/(kg.d)] or FK506 [0.18 - 0.25 mg/(kg.d)], mycophenolate mofetil [MMF 10 - 15 mg/(kg.d)] or azathioprine [1 - 3 mg/(kg.d)] and prednisone [0.4 - 0.6 mg/(kg.d)]. High-dose methylprednisolone [10 mg/(kg.d)] was administered to control the acute rejection.
RESULTSThe renal function of patients was restored 5.6 days in average after transplantations. The 1st, 3rd and 5th year survival rates of recipient/graft were 95.2%/95.2%, 86.7%/73.3% and 72.7%/63.6%, respectively. One case had super-acute renal rejection, 5 cases had acute rejection, 3 cases had delayed graft function and 3 patients died. The longest survival time was 12 years. The major complications included hypertension (47.6%), diabetes (19.4%), infection (19.4%) and drug-induced hepatic injury (14.2%). Catch-up growth was seen in most of the pediatric recipients.
CONCLUSIONRenal transplantation is the most ideal method to treat children with ESRD, and the growth of the pediatric patients will be improved after transplantation. Adult donor kidneys adapt to the school age patient. And the protocol of immunosuppressive therapy (prednisone plus MMF and FK506) should be applied.
Adolescent ; Adult ; Child ; Female ; Histocompatibility Testing ; Humans ; Kidney Failure, Chronic ; mortality ; therapy ; Kidney Transplantation ; Male ; Postoperative Care ; Preoperative Care ; Prognosis ; Survival Rate ; Time Factors
10.Diabetic kidney disease: seven questions
Journal of the Korean Medical Association 2020;63(1):6-13
Diabetic kidney disease is a microvascular complication of diabetes mellitus and the leading cause of end-stage renal disease resulting in renal replacement therapy. Approximately 30% to 40% of diabetic patients have diabetic kidney disease, which contributes to a significant increase in morbidity and mortality. Microalbuminuria is considered the gold standard for diabetic kidney disease diagnosis; however, its predictive value is restricted. Although blood glucose control, blood pressure control, and angiotensin converting enzyme inhibitors have been the primary treatment strategies, there are no definitive treatment modalities capable of inhibiting the progression of kidney dysfunction in these patients. This study was undertaken to answer seven questions regarding the various aspects of diabetic kidney disease. Why does it develop? what kind of factors affect its development? How is it diagnosed? What are its possible biomarkers? When is a kidney biopsy necessary? What are the preventive and therapeutic options? And what are the novel treatments?
Angiotensin-Converting Enzyme Inhibitors
;
Biomarkers
;
Biopsy
;
Blood Glucose
;
Blood Pressure
;
Diabetes Mellitus
;
Diabetic Nephropathies
;
Diagnosis
;
Humans
;
Kidney
;
Kidney Failure, Chronic
;
Mortality
;
Renal Replacement Therapy